Lobo R

ORCID: 0009-0004-1578-9793 · 4 papers in corpus · active 2012-2025

Study types

  • review 1

Condition tags

  • endometriosis 1
2025
One-year cumulative live birth rate associated with the number of oocytes in ovarian stimulation with follitropin delta: a pooled analysis of four randomized controlled trials.
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deaf111

Study questionWhat number of oocytes retrieved is associated with the highest cumulative live birth rates (CLBRs) in the fresh and subsequent frozen cycles following ovarian stimulation with follitropin delta?Summary answerThe CLBR increase…

2025
Ovarian stimulation with follitropin delta for in vitro fertilization: a multicentre, randomized, assessor-blind comparison with follitropin alfa using conventional dosing regimens (ADAPT-1 trial).
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deaf119

Study questionHow do ovarian responses using conventional dosing for follitropin delta 15 µg/day compare with follitropin alfa 225 IU/day in women undergoing ovarian stimulation?Summary answerThe ADAPT-1 trial demonstrates similar ovarian r…

2024
BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle.
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deae092

Study questionHow does a gonadotrophin-releasing hormone (GnRH) agonist versus a GnRH antagonist protocol affect ovarian response when using an individualized fixed daily dose of follitropin delta for ovarian stimulation?Summary answerThe B…

review 2012
Best practices of ASRM and ESHRE: a journey through reproductive medicine
Human Reproduction ·doi:10.1093/humrep/des338

BACKGROUND: The American Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embryology (ESHRE) are the two largest societies in the world whose members comprise the major experts and professionals wo…